We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $672B
1-Year Est. Return 33.48%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+33.48%
3 Year Est. Return
+94.84%
5 Year Est. Return
+111.06%
10 Year Est. Return
+380.55%
AUM
$369B
AUM Growth
-$12.1B
Cap. Flow
+$4.11B
Cap. Flow %
1.11%
Top 10 Hldgs %
19.35%
Holding
8,011
New
401
Increased
3,689
Reduced
2,722
Closed
533

Sector Composition

Rank Sector Weight
1 Financials 18.14%
2 Technology 14.39%
3 Healthcare 7.84%
4 Industrials 7.61%
5 Energy 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCI icon
6176
Transcontinental Realty Investors
TCI
$315M
$15K ﹤0.01%
491
-229
-32% -$7.72K
TEMP
6177
DELISTED
JPMorgan Climate Change Solutions ETF
TEMP
$15K ﹤0.01%
400
TRVI icon
6178
Trevi Therapeutics
TRVI
$2.63B
$15K ﹤0.01%
6,988
+2,645
+61% +$5.98K
USEP icon
6179
Innovator US Equity Ultra Buffer ETF September
USEP
$146M
$15K ﹤0.01%
+511
New +$15.1K
VOR icon
6180
Vor Biopharma
VOR
$1.36B
$15K ﹤0.01%
357
+160
+81% +$8.68K
VTGN icon
6181
VistaGen Therapeutics
VTGN
$11.9M
$15K ﹤0.01%
2,860
+2,711
+1,819% +$12K
OKUR
6182
OnKure Therapeutics
OKUR
$162M
$15K ﹤0.01%
198
+103
+108% +$7.01K
MAGN
6183
Magnera Corp
MAGN
$444M
$15K ﹤0.01%
572
+217
+61% +$7.22K
WHWK
6184
Whitehawk Therapeutics
WHWK
$254M
$15K ﹤0.01%
3,084
+341
+12% +$1.98K
LBC
6185
DELISTED
Luther Burbank Corporation Common Stock
LBC
$15K ﹤0.01%
1,877
+807
+75% +$7.49K
LBPH
6186
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$15K ﹤0.01%
2,670
+919
+52% +$5.92K
AFRI icon
6187
Forafric Global
AFRI
$286M
$14K ﹤0.01%
1,250
+156
+14% +$1.73K
AKYA
6188
DELISTED
Akoya BioSciences
AKYA
$14K ﹤0.01%
3,157
+1,724
+120% +$9.91K
ARHS icon
6189
Arhaus
ARHS
$1.39B
$14K ﹤0.01%
1,455
-8,982
-86% -$94.1K
BKKT icon
6190
Bakkt Inc
BKKT
$342M
$14K ﹤0.01%
468
+97
+26% +$3.44K
BLZE icon
6191
Backblaze
BLZE
$1.18B
$14K ﹤0.01%
2,462
+279
+13% +$1.51K
CRNT icon
6192
Ceragon Networks
CRNT
$200M
$14K ﹤0.01%
7,270
+141
+2% +$285
CTSO icon
6193
Cytosorbents Corp
CTSO
$25.1M
$14K ﹤0.01%
7,529
+2,356
+46% +$6.76K
CTXR icon
6194
Citius Pharmaceuticals
CTXR
$20.7M
$14K ﹤0.01%
802
+303
+61% +$7.2K
DSTL icon
6195
Distillate US Fundamental Stability & Value ETF
DSTL
$2.08B
$14K ﹤0.01%
316
-10,350
-97% -$475K
GILT icon
6196
Gilat Satellite Networks
GILT
$887M
$14K ﹤0.01%
2,269
+543
+31% +$3.52K
GNSS icon
6197
Genasys
GNSS
$78.8M
$14K ﹤0.01%
6,987
+783
+13% +$2.33K
KZR
6198
DELISTED
Kezar Life Sciences
KZR
$14K ﹤0.01%
1,198
+452
+61% +$8.01K
LTRX icon
6199
Lantronix
LTRX
$289M
$14K ﹤0.01%
3,091
+1,672
+118% +$7.34K
MFEM icon
6200
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
MFEM
$151M
$14K ﹤0.01%
750
-2,149
-74% -$40.1K

Similar funds

Royal Bank of Canada's Q3 2023 Portfolio in Review

As of Q3 2023, Royal Bank of Canada held 8,011 positions worth $369B, down 3.2% from $381B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada's Q3 2023 filing shows 401 new, 3,689 increased, 2,722 reduced and 533 closed positions. Its largest new stake was PGIM AAA CLO ETF: 210,232 shares worth $10.6M. The largest sale was iShares Core S&P 500 ETF, an estimated $931M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • Royal Bank of Canada's largest Q3 2023 buy was PGIM AAA CLO ETF: 210,232 shares worth $10.6M.
  • Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $1.1B increase.
  • Royal Bank of Canada's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $931M.
  • Royal Bank of Canada fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $19.9M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $369B portfolio in Q3 2023.
  • Royal Bank of Canada opened 401 new positions and closed 533 in Q3 2023.
  • Royal Bank of Canada's portfolio value fell 3.2% quarter-over-quarter to $369B.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.